A Comparison of mXELIRI Regimen and FOLFIRI Combined Bevacizumab Regimen as First-line Chemotherapy Regimen for Metastatic Colorectal Cancer
收藏NIAID Data Ecosystem2026-03-10 收录
下载链接：
https://www.omicsdi.org/dataset/ecrin-mdr-crc/2328450
下载链接
链接失效反馈官方服务：
资源简介：
This is a Phase II, multicenter，randomized, two arms, open-labeled, controlled clinical trial. This trial was conducted to evaluate the efficacy and safety of bevacizumab (Avastin) plus mXELIRI compared with bevacizumab (Avastin) plus FOLFIRI as first-line treatment in patients with metastatic colorectal cancer (mCRC).
创建时间：
2018-05-15
